ArticleOncogene2020
HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients.
M Burgess et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleOncogene2020
M Burgess et al.PubMed ↗Publisher ↗
No numbers read from the abstract.